经胎盘给予地高辛治疗胎儿室上性心律失常：来自中国胎儿的见解。 - Suppr

Transplacental digoxin treatment for fetal supraventricular arrhythmias: Insights from Chinese fetuses.

作者信息

Wang Chuan, Zhao Li, Shao Shuran, Yu Haiyan, Zhou Shu, Li Yifei, Zhu Qi, Liu Xiaoliang, Duan Hongyu, Liu Hanmin, Hua Yimin, Zhou Kaiyu

机构信息

Key Laboratory of Birth Defects and Related Diseases of Women and Children of MOE, Department of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu, Sichuan 610041, China.

Department of Postgraduate Students, West China Medical School of Sichuan University, Chengdu, Sichuan 610041, China.

出版信息

Chin Med J (Engl). 2025 Jun 20;138(12):1499-1501. doi: 10.1097/CM9.0000000000003583. Epub 2025 Apr 9.

DOI:10.1097/CM9.0000000000003583

PMID:40204513

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12180843/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30e4/12180843/066eacc8aad7/cm9-138-1499-g001.jpg

相似文献

Transplacental digoxin treatment for fetal supraventricular arrhythmias: Insights from Chinese fetuses.

Chin Med J (Engl). 2025 Jun 20;138(12):1499-1501. doi: 10.1097/CM9.0000000000003583. Epub 2025 Apr 9.

[Intrauterine therapy of fetal supraventricular tachycardia with digoxin and verapamil].

Z Geburtshilfe Perinatol. 1993 Mar-Apr;197(2):99-103.

High-dose flecainide is the most effective treatment of fetal supraventricular tachycardia.

Heart Rhythm. 2016 Jun;13(6):1283-8. doi: 10.1016/j.hrthm.2016.01.029. Epub 2016 Jan 29.

Fetal supraventricular tachycardia complicated by hydrops fetalis: a role for direct fetal intramuscular therapy.

Am J Perinatol. 1996 Nov;13(8):483-6. doi: 10.1055/s-2007-994432.

First-Line Antiarrhythmic Transplacental Treatment for Fetal Tachyarrhythmia: A Systematic Review and Meta-Analysis.

J Am Heart Assoc. 2017 Dec 15;6(12):e007164. doi: 10.1161/JAHA.117.007164.

Fetal supraventricular tachycardia and hydrops fetalis: combined intensive, direct, and transplacental therapy.

Obstet Gynecol. 1991 Sep;78(3 Pt 2):523-5.

Fetal tachycardias: management and outcome of 127 consecutive cases.

Heart. 1998 Jun;79(6):576-81.

The efficacy of flecainide versus digoxin in the management of fetal supraventricular tachycardia.

Prenat Diagn. 1995 Dec;15(13):1297-302. doi: 10.1002/pd.1970151309.

Transplacental Therapeutic Drug Monitoring in Pregnant Women with Fetal Tachyarrhythmia Using HPLC-MS/MS.

Int J Mol Sci. 2023 Jan 17;24(3):1848. doi: 10.3390/ijms24031848.

Flecainide versus digoxin for fetal supraventricular tachycardia: Comparison of two drug treatment protocols.

Heart Rhythm. 2016 Sep;13(9):1913-9. doi: 10.1016/j.hrthm.2016.03.023.

本文引用的文献

Pharmacological Management of Cardiac Arrhythmias in the Fetal and Neonatal Periods: A Scientific Statement From the American Heart Association: Endorsed by the Pediatric & Congenital Electrophysiology Society (PACES).

Circulation. 2024 Mar 5;149(10):e937-e952. doi: 10.1161/CIR.0000000000001206. Epub 2024 Feb 5.

2023 HRS expert consensus statement on the management of arrhythmias during pregnancy.

Heart Rhythm. 2023 Oct;20(10):e175-e264. doi: 10.1016/j.hrthm.2023.05.017. Epub 2023 May 19.

Antenatal Therapy for Fetal Supraventricular Tachyarrhythmias: Multicenter Trial.

J Am Coll Cardiol. 2019 Aug 20;74(7):874-885. doi: 10.1016/j.jacc.2019.06.024.

Diagnosis and treatment of fetal cardiac disease: a scientific statement from the American Heart Association.

Circulation. 2014 May 27;129(21):2183-242. doi: 10.1161/01.cir.0000437597.44550.5d. Epub 2014 Apr 24.

Comparison of transplacental treatment of fetal supraventricular tachyarrhythmias with digoxin, flecainide, and sotalol: results of a nonrandomized multicenter study.

Circulation. 2011 Oct 18;124(16):1747-54. doi: 10.1161/CIRCULATIONAHA.111.026120. Epub 2011 Sep 19.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Transplacental digoxin treatment for fetal supraventricular arrhythmias: Insights from Chinese fetuses.

作者信息

Wang Chuan, Zhao Li, Shao Shuran, Yu Haiyan, Zhou Shu, Li Yifei, Zhu Qi, Liu Xiaoliang, Duan Hongyu, Liu Hanmin, Hua Yimin, Zhou Kaiyu

机构信息

Key Laboratory of Birth Defects and Related Diseases of Women and Children of MOE, Department of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu, Sichuan 610041, China.

Department of Postgraduate Students, West China Medical School of Sichuan University, Chengdu, Sichuan 610041, China.

出版信息

Chin Med J (Engl). 2025 Jun 20;138(12):1499-1501. doi: 10.1097/CM9.0000000000003583. Epub 2025 Apr 9.

DOI:10.1097/CM9.0000000000003583

PMID:40204513

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12180843/

Abstract

摘要

相似文献

Transplacental digoxin treatment for fetal supraventricular arrhythmias: Insights from Chinese fetuses.

Chin Med J (Engl). 2025 Jun 20;138(12):1499-1501. doi: 10.1097/CM9.0000000000003583. Epub 2025 Apr 9.

[Intrauterine therapy of fetal supraventricular tachycardia with digoxin and verapamil].

Z Geburtshilfe Perinatol. 1993 Mar-Apr;197(2):99-103.

High-dose flecainide is the most effective treatment of fetal supraventricular tachycardia.

Heart Rhythm. 2016 Jun;13(6):1283-8. doi: 10.1016/j.hrthm.2016.01.029. Epub 2016 Jan 29.

Fetal supraventricular tachycardia complicated by hydrops fetalis: a role for direct fetal intramuscular therapy.

Am J Perinatol. 1996 Nov;13(8):483-6. doi: 10.1055/s-2007-994432.

First-Line Antiarrhythmic Transplacental Treatment for Fetal Tachyarrhythmia: A Systematic Review and Meta-Analysis.

J Am Heart Assoc. 2017 Dec 15;6(12):e007164. doi: 10.1161/JAHA.117.007164.

Fetal supraventricular tachycardia and hydrops fetalis: combined intensive, direct, and transplacental therapy.

Obstet Gynecol. 1991 Sep;78(3 Pt 2):523-5.

Fetal tachycardias: management and outcome of 127 consecutive cases.

Heart. 1998 Jun;79(6):576-81.

The efficacy of flecainide versus digoxin in the management of fetal supraventricular tachycardia.

Prenat Diagn. 1995 Dec;15(13):1297-302. doi: 10.1002/pd.1970151309.

Transplacental Therapeutic Drug Monitoring in Pregnant Women with Fetal Tachyarrhythmia Using HPLC-MS/MS.

Int J Mol Sci. 2023 Jan 17;24(3):1848. doi: 10.3390/ijms24031848.

Flecainide versus digoxin for fetal supraventricular tachycardia: Comparison of two drug treatment protocols.

Heart Rhythm. 2016 Sep;13(9):1913-9. doi: 10.1016/j.hrthm.2016.03.023.

本文引用的文献

Circulation. 2024 Mar 5;149(10):e937-e952. doi: 10.1161/CIR.0000000000001206. Epub 2024 Feb 5.

2023 HRS expert consensus statement on the management of arrhythmias during pregnancy.

Heart Rhythm. 2023 Oct;20(10):e175-e264. doi: 10.1016/j.hrthm.2023.05.017. Epub 2023 May 19.

Antenatal Therapy for Fetal Supraventricular Tachyarrhythmias: Multicenter Trial.

J Am Coll Cardiol. 2019 Aug 20;74(7):874-885. doi: 10.1016/j.jacc.2019.06.024.

Diagnosis and treatment of fetal cardiac disease: a scientific statement from the American Heart Association.

Circulation. 2014 May 27;129(21):2183-242. doi: 10.1161/01.cir.0000437597.44550.5d. Epub 2014 Apr 24.

Comparison of transplacental treatment of fetal supraventricular tachyarrhythmias with digoxin, flecainide, and sotalol: results of a nonrandomized multicenter study.

Circulation. 2011 Oct 18;124(16):1747-54. doi: 10.1161/CIRCULATIONAHA.111.026120. Epub 2011 Sep 19.

Transplacental digoxin treatment for fetal supraventricular arrhythmias: Insights from Chinese fetuses.

作者信息

机构信息

出版信息

相似文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Transplacental digoxin treatment for fetal supraventricular arrhythmias: Insights from Chinese fetuses.

作者信息

机构信息

出版信息

相似文献

本文引用的文献